Paper Details

Paper Title

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Paper Journal Title

Ann Oncol

Paper Citation Count

Paper Publication Year

2017

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Stefan Aebi

Column Actions